Berenberg Bank Issues Positive Forecast for Lam Research (NASDAQ:LRCX) Stock Price

Key Points

• Berenberg Bank has raised its target price for Lam Research from $122.00 to $165.00, indicating a potential upside of 18.56% from the stock's previous close and maintaining a "buy" rating.
• Lam Research reported a 27.7% year-over-year revenue growth with earnings per share of $1.26 for the last quarter, exceeding analyst expectations.
• The company currently maintains an average rating of "Moderate Buy" among analysts, with 25 ratings as "Buy" and a consensus target price of $143.69.

Lam Research (NASDAQ:LRCX - Get Free Report) had its target price lifted by research analysts at Berenberg Bank from $122.00 to $165.00 in a research report issued on Thursday,MarketScreener reports. The brokerage currently has a "buy" rating on the semiconductor company's stock. Berenberg Bank's price objective indicates a potential upside of 18.56% from the stock's previous close.

Other equities research analysts have also recently issued research reports about the stock. Wells Fargo & Company upped their price objective on shares of Lam Research from $98.00 to $135.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 2nd. Weiss Ratings restated a "buy (b-)" rating on shares of Lam Research in a research report on Wednesday, October 8th. UBS Group set a $165.00 price target on shares of Lam Research and gave the stock a "buy" rating in a report on Thursday. Oppenheimer set a $200.00 price objective on shares of Lam Research and gave the company an "outperform" rating in a research note on Thursday. Finally, Stifel Nicolaus set a $160.00 price objective on shares of Lam Research in a research report on Thursday. One research analyst has rated the stock with a Strong Buy rating, twenty-five have assigned a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus target price of $143.69.

Lam Research Trading Down 1.5%

Shares of LRCX stock opened at $139.17 on Thursday. The stock has a market cap of $175.50 billion, a P/E ratio of 33.54, a price-to-earnings-growth ratio of 1.76 and a beta of 1.84. Lam Research has a 1 year low of $56.32 and a 1 year high of $153.70. The company has a current ratio of 2.21, a quick ratio of 1.55 and a debt-to-equity ratio of 0.38. The stock has a 50 day simple moving average of $121.38 and a 200 day simple moving average of $98.38.

Lam Research (NASDAQ:LRCX - Get Free Report) last posted its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 EPS for the quarter, topping analysts' consensus estimates of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.23 billion. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The company's revenue was up 27.7% on a year-over-year basis. During the same quarter last year, the company earned $0.86 EPS. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, research analysts predict that Lam Research will post 3.71 earnings per share for the current fiscal year.

Insider Buying and Selling

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the company's stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $138.90, for a total value of $7,249,191.00. Following the sale, the senior vice president owned 251,047 shares in the company, valued at approximately $34,870,428.30. The trade was a 17.21% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.31% of the company's stock.

Hedge Funds Weigh In On Lam Research

A number of hedge funds and other institutional investors have recently made changes to their positions in the stock. IMG Wealth Management Inc. bought a new position in Lam Research during the 2nd quarter worth approximately $26,000. Howard Hughes Medical Institute bought a new position in Lam Research during the second quarter worth $27,000. Sound Income Strategies LLC acquired a new position in Lam Research in the third quarter valued at $41,000. Tripletail Wealth Management LLC acquired a new position in Lam Research in the third quarter valued at $44,000. Finally, Strategic Wealth Investment Group LLC bought a new stake in Lam Research during the second quarter valued at $29,000. 84.61% of the stock is owned by institutional investors and hedge funds.

About Lam Research

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.